These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 4211699)
21. Immunotherapy of cancer: a critical review. Lutz D Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):118-29. PubMed ID: 6343261 [TBL] [Abstract][Full Text] [Related]
22. [Effect of immune processes on the growth and regression of malignant tumors]. Russo V; Russo L Vopr Onkol; 1974; 20(6):68-75. PubMed ID: 4603500 [No Abstract] [Full Text] [Related]
23. Current aspects of tumor immunology. Preface and introduction. Weiss DW Isr J Med Sci; 1973 Mar; 9(3):205-16. PubMed ID: 4575649 [No Abstract] [Full Text] [Related]
24. [Cancer therapy and the immune response of the body]. Bergol'ts VM Vopr Onkol; 1970; 16(12):82-93. PubMed ID: 4932064 [No Abstract] [Full Text] [Related]
25. [Immunology and cancer]. Brunner KT Schweiz Med Wochenschr; 1973 Sep; 103(36):1249-52. PubMed ID: 4584090 [No Abstract] [Full Text] [Related]
26. [Immunotherapy of acute leukoses]. Krepler P Krebsarzt; 1969; 24(4):208-20. PubMed ID: 4190048 [No Abstract] [Full Text] [Related]
27. [Trends in the immunologic studies of tumors in man]. Noda M Saishin Igaku; 1971 Sep; 26(9):1750-4. PubMed ID: 4938186 [No Abstract] [Full Text] [Related]
28. [Immunity reactions and the pharmacotherapy of malignant neoplasms (allergy and cancer)]. Ado VA Fiziol Zh; 1976; 22(2):265-71. PubMed ID: 791690 [No Abstract] [Full Text] [Related]
29. Prospects for tumor immunotherapy in man, with emphasis on its use as an adjunct to surgery for primary operable cancer. Southam CM J Med Liban; 1975; 28(1):43-66. PubMed ID: 1107552 [No Abstract] [Full Text] [Related]
30. Introduction: diagnosis and immunotherapy of cancer. Klein E Natl Cancer Inst Monogr; 1972 Dec; 35():331-9. PubMed ID: 4349151 [No Abstract] [Full Text] [Related]
32. [Tumours and immunity. II. Special part. Tumour antigens. The immune response by neoplasms. Immunotherapy]. Ulvund MJ Nord Vet Med; 1972; 24(7):380-7. PubMed ID: 4666480 [No Abstract] [Full Text] [Related]
33. The passive immunotherapy of murine leukaemia. I. The production of antisera against leukaemic antigens. Motta R Rev Eur Etud Clin Biol; 1970 Feb; 15(2):161-7. PubMed ID: 4315341 [No Abstract] [Full Text] [Related]
35. Cancer vaccine development: on the way to break immune tolerance to malignant cells. Mocellin S; Rossi CR; Nitti D Exp Cell Res; 2004 Oct; 299(2):267-78. PubMed ID: 15350526 [TBL] [Abstract][Full Text] [Related]
36. Cancer vaccines and immunotherapies: emerging perspectives. Henderson RA; Mossman S; Nairn N; Cheever MA Vaccine; 2005 Mar; 23(17-18):2359-62. PubMed ID: 15755628 [TBL] [Abstract][Full Text] [Related]
38. [Immunological treatment of leukemias]. Szmigiel Z Pol Tyg Lek; 1971 Mar; 26(13):482-4. PubMed ID: 4929907 [No Abstract] [Full Text] [Related]
39. [Introduction to the International Symposium on Tumor Immunotherapy]. De Barbieri A Boll Ist Sieroter Milan; 1971; 50(3):137-9. PubMed ID: 5146576 [No Abstract] [Full Text] [Related]